As far as cancer is concerned, PUS1 modulates interactions between SRA1 and estrogen receptor in breast cancer, PUS7 has a putative role in ovarian cancer diagnosis, while in prostate cells, PUS10 regulates TNF-related apoptosis-inducing ligand (TRAIL) [143,144,145]. Here, TNFSF10 is linked to ovarian carcinoma.